GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
The Rise of Multi-Cancer Early Detection: Transforming Cancer Diagnostics The landscape of cancer diagnostics is undergoing a transformative shift, as technologies like the Galleri® Test offer earlier detection of multiple cancer types. This advancement leverages circulating tumor DNA (ctDNA) and targeted methylation assays, revolutionizing how we approach cancer screening and management. A New Era of … Read more